Efficacy and Safety of Patritumab Deruxtecan (HER3-DXd) in EGFR Inhibitor-Resistant, EGFR-Mutated Non-Small Cell Lung Cancer.
Cancer Discovery
Jänne, Pasi A PA; Baik, Christina C; Su, Wu-Chou WC; Johnson, Melissa L ML; Hayashi, Hidetoshi H; Nishio, Makoto M; Kim, Dong-Wan DW; Koczywas, Marianna M; Gold, Kathryn A KA; Steuer, Conor E CE; Murakami, Haruyasu H; Yang, James Chih-Hsin JC; Kim, Sang-We SW; Vigliotti, Michele M; Shi, Rong R; Qi, Zhenhao Z; Qiu, Yang Y; Zhao, Lihui L; Sternberg, David D; Yu, Channing C; Yu, Helena A HA